Reactivation of Tuberculosis in Three Cases of Psoriasis after Initiation of Anti-TNF Therapy

被引：10
作者：
Abu Shaikha, Samya [1 ]
Mansour, Khalid [1 ]
Riad, Hassan [1 ]
机构：
[1] Hamad Med Corp, Dept Dermatol, Doha, Qatar
来源：
CASE REPORTS IN DERMATOLOGY | 2012年 / 4卷 / 01期
关键词：
Psoriasis; Tuberculosis; Biologics; Reactivation;
D O I：
10.1159/000337145
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
New biological therapies for disabling diseases such as psoriasis may carry both short- and long-term risks. Tuberculosis (TB) reactivation is a frequent complication of anti-tumor necrosis factor (TNF) therapy. We present 3 cases of psoriasis that were treated with different types of anti-TNF and developed TB infection (TBI) during therapy. One of the cases was diagnosed as active pulmonary TB and the other 2 cases as latent TBI. All cases received appropriate anti-TB treatment, and the anti-TNF therapy was interrupted and then resumed according to various clinical considerations.
引用
收藏
页码：41 / 46
页数：6
相关论文
共 12 条
[1]  
[Anonymous], 2011, WHO REP
[2]   Patients with Psoriasis are More Likely to be Treated for Latent Tuberculosis Infection Prior to Biologics than Patients with Inflammatory Bowel Disease [J].
Bassukas, Ioannis D. ;
Kosmidou, Maria ;
Gaitanis, Georgios ;
Tsiouri, Georgia ;
Tsianos, Epameinondas .
ACTA DERMATO-VENEREOLOGICA, 2011, 91 (04) :444-446
[3]  
Bordignon V, 2011, J BIOL REG HOMEOS AG, V25, P213
[4]   Clinical experience of QuantiFERON®-TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan [J].
Chiu, H-Y. ;
Hsueh, P-R. ;
Tsai, T-F. .
BRITISH JOURNAL OF DERMATOLOGY, 2011, 164 (03) :553-559
[5]   National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents [J].
Doherty, Sean D. ;
Van Voorhees, Abby ;
Lebwohl, Mark G. ;
Korman, Neil J. ;
Young, Melodie S. ;
Hsu, Sylvia .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (02) :209-217
[6]   Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis [J].
Garcia-Rodriguez, S ;
Arias-Santiago, S ;
Perandres-Lopez, R ;
Castellote, L ;
Zumaquero, E ;
Navarro, P ;
Buendia-Eisman, A ;
Ruiz, J-C ;
Orgaz-Molina, J ;
Sancho, J ;
Zubiaur, M .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (02) :242-250
[7]   Time for a change? Updated guidelines using interferon gamma release assays for detection of latent tuberculosis infection in the office setting [J].
Kardos, Marisa ;
Kimball, Alexa Boer .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (01) :148-152
[8]   Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-γ release assay vs. tuberculin skin test [J].
Laffitte, E. ;
Janssens, J. P. ;
Roux-Lombard, P. ;
Thielen, A. M. ;
Barde, C. ;
Marazza, G. ;
Panizzon, R. G. ;
Saurat, J-H. .
BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (04) :797-800
[9]   European S3-Guidelines on the systemic treatment of psoriasis vulgaris [J].
Pathirana, D. ;
Ormerod, A. D. ;
Saiag, P. ;
Smith, C. ;
Spuls, P. I. ;
Nast, A. ;
Barker, J. ;
Bos, J. D. ;
Burmester, G-R ;
Chimenti, S. ;
Dubertret, L. ;
Eberlein, B. ;
Erdmann, R. ;
Ferguson, J. ;
Girolomoni, G. ;
Gisondi, P. ;
Giunta, A. ;
Griffiths, C. ;
Hoenigsmann, H. ;
Hussain, M. ;
Jobling, R. ;
Karvonen, S-L ;
Kemeny, L. ;
Kopp, I. ;
Leonardi, C. ;
Maccarone, M. ;
Menter, A. ;
Mrowietz, U. ;
Naldi, L. ;
Nijsten, T. ;
Ortonne, J-P ;
Orzechowski, H-D ;
Rantanen, T. ;
Reich, K. ;
Reytan, N. ;
Richards, H. ;
Thio, H. B. ;
van de Kerkhof, P. ;
Rzany, B. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 :1-70
[10]   Tuberculosis and tumour necrosis factor-α inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians [J].
Perlmutter, A. ;
Mittal, A. ;
Menter, A. .
BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (01) :8-15
12